-
Rules for Labels of Prepared Slices of Chinese Crude Drugs Issued by China NMPA
2023-07-14
The NMPA organized to formulate the Rules for Labels of Prepared Slices of Chinese Crude Drugs, which is hereby released and shall be implemented since August 1, 2024.
-
Chinese drug regulators launch safety crackdown
2023-06-29
China's National Medical Products Administration has recently launched a nationwide drug safety consolidation and enhancement campaign to establish a solid foundation for drug safety.
-
Supervision tightened on cosmetic medicine
2023-05-15
Eleven central departments including the State Administration for Market Regulation, the National Health Commission and the Ministry of Public Security recently released a guideline to strengthen supervision of the medical cosmetology industry to regulate the industry's development and protect consumers' rights.
-
Supervision ensures medical products safe
2023-07-06
With the sale of medical products online skyrocketing in recent years, the National Medical Products Administration has led a crackdown to ensure only safe and approved products are available for consumers.
-
Announcement of the Center for Food and Drug Inspection of NMPA on Issuing 5 Documents including the Work Procedures for Drug Registration Inspection (Trial) (No. 30 of 2021)
2022-10-11
According to the Provisions for Drug Registration, to clarify the principles, procedures, time limits and requirements of drug registration inspection, to regulate the collaborative between manufacturing site inspection of drug registration and pre-market Good Manufacturing Practice (GMP) inspection, CFDI has organized to formulate the 5 documents
-
NMPA Announcement on Issuing the List of Medical Devices Prohibited from Contract Manufacturing
2022-03-24
The National Medical Products Administration organized to revise the List of Medical Devices Prohibited from Contract Manufacturing, which was issued on March 11, 2022 and will take effect on May 1, 2022.